BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25315315)

  • 1. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
    Chang JI; Hazboun RC; Chang TI
    J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
    [No Abstract]   [Full Text] [Related]  

  • 2. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
    Schwartz HC
    J Oral Maxillofac Surg; 2015 Mar; 73(3):377. PubMed ID: 25683041
    [No Abstract]   [Full Text] [Related]  

  • 3. In reply.
    Ruggiero SL; Dodson TB
    J Oral Maxillofac Surg; 2014 Dec; 72(12):2381-2. PubMed ID: 25305084
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: To PMID 25234529.
    Ruggiero SL
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1239-40. PubMed ID: 25913511
    [No Abstract]   [Full Text] [Related]  

  • 5. C-Terminal Telopeptide—Science or Politics?
    Schwartz HC
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1239. PubMed ID: 25930959
    [No Abstract]   [Full Text] [Related]  

  • 6. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
    Ruggiero SL; Dodson TB; Fantasia J; Goodday R; Aghaloo T; Mehrotra B; O'Ryan F;
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1938-56. PubMed ID: 25234529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflibercept: osteonecrosis of the jaw: Watch out for high-risk situations.
    Prescrire Int; 2016 Nov; 25(176):271. PubMed ID: 30730125
    [No Abstract]   [Full Text] [Related]  

  • 9. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: AAOMS Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.
    Campisi G; Mauceri R; Bedogni A; Fusco V
    J Oral Maxillofac Surg; 2022 Nov; 80(11):1723-1724. PubMed ID: 36332990
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
    Aragon-Ching JB; Dahut WL
    Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
    [No Abstract]   [Full Text] [Related]  

  • 16. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A; Terpos E; Dimopoulos MA
    Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: golimumab-related osteonecrosis of the jaw.
    Ghosh YA; Pullara J; Rattan R; Melville JC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Nov; 136(5):e149-e152. PubMed ID: 37661466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2011; 59(6):410-3. PubMed ID: 22313910
    [No Abstract]   [Full Text] [Related]  

  • 20. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.